On the public citation graph

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis

0 signed · 282 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.1840020202openalex-snapshot
A Prospective Morphologic Evaluation of Hepatic Toxicity of Chenodeoxycholic Acid in Patients With Cholelithiasis: the National Cooperative Gallstone Study
inferredcites →https://doi.org/10.1002/hep.1840120523openalex-snapshot
Hepatic injury induced by bile salts: Correlation between biochemical and morphological events
inferredcites →https://doi.org/10.1002/hep.20466openalex-snapshot
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
inferredcites →https://doi.org/10.1002/hep.20701openalex-snapshot
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
inferredcites →https://doi.org/10.1002/hep.21287openalex-snapshot
Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency
inferredcites →https://doi.org/10.1002/hep.22627openalex-snapshot
Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression†
inferredcites →https://doi.org/10.1002/hep.23050openalex-snapshot
Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.23721openalex-snapshot
Transgenic expression of cholesterol 7α‐hydroxylase in the liver prevents high‐fat diet–induced obesity and insulin resistance in mice†
inferredcites →https://doi.org/10.1002/hep.24097openalex-snapshot
Gender-Specific Differences in Adipose Distribution and Adipocytokines Influence Adolescent Nonalcoholic Fatty Liver Disease Δ
inferredcites →https://doi.org/10.1007/bf03401914openalex-snapshot
Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production
inferredcites →https://doi.org/10.1007/s11695-010-0204-1openalex-snapshot
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
inferredcites →https://doi.org/10.1016/0014-5793(88)80944-xopenalex-snapshot
Levels of 7α‐hydroxy‐4‐cholesten‐3‐one in plasma reflect rates of bile acid synthesis in man
inferredcites →https://doi.org/10.1016/j.abb.2004.09.019openalex-snapshot
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
inferredcites →https://doi.org/10.1016/j.bbamcr.2006.04.014openalex-snapshot
Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration
inferredcites →https://doi.org/10.1016/j.bbrc.2008.04.113openalex-snapshot
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
inferredcites →https://doi.org/10.1016/j.cld.2007.02.011openalex-snapshot
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
inferredcites →https://doi.org/10.1016/j.dld.2010.03.015openalex-snapshot
Bile salts and cholestasis
inferredcites →https://doi.org/10.1016/j.jhep.2008.08.023openalex-snapshot
Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C
inferredcites →https://doi.org/10.1016/j.jhep.2010.01.005openalex-snapshot
Impaired liver regeneration of steatotic rats after portal vein ligation: A particular emphasis on 99mTc-DISIDA scintigraphy and adiponectin signaling
inferredcites →https://doi.org/10.1016/j.jhep.2011.08.025openalex-snapshot
The interaction of hepatic lipid and glucose metabolism in liver diseases
inferredcites →https://doi.org/10.1016/j.metabol.2009.05.006openalex-snapshot
Serum bile acid along with plasma incretins and serum high–molecular weight adiponectin levels are increased after bariatric surgery
inferredcites →https://doi.org/10.1016/j.yexmp.2012.03.008openalex-snapshot
Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice
inferredcites →https://doi.org/10.1016/s0022-3565(24)35228-0openalex-snapshot
Modulation by Drugs of Human Hepatic Sodium-Dependent Bile Acid Transporter (Sodium Taurocholate Cotransporting Polypeptide) Activity
inferredcites →https://doi.org/10.1016/s0168-8278(00)80200-7openalex-snapshot
Mitochondrial membrane perturbations in cholestasis
inferredcites →https://doi.org/10.1016/s1097-2765(00)00051-4openalex-snapshot
A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis
inferredcites →https://doi.org/10.1016/s1590-8658(02)80033-0openalex-snapshot
Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease
inferredcites →https://doi.org/10.1038/labinvest.2010.107openalex-snapshot
Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice
inferredcites →https://doi.org/10.1053/gast.2001.21176openalex-snapshot
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
inferredcites →https://doi.org/10.1053/gast.2001.25503openalex-snapshot
The Orphan Nuclear Receptor, shp, Mediates Bile Acid-Induced Inhibition of the Rat Bile Acid Transporter, ntcp
inferredcites →https://doi.org/10.1053/gast.2002.33583openalex-snapshot
Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor
inferredcites →https://doi.org/10.1053/j.gastro.2003.06.005openalex-snapshot
Enterohepatic bile salt transporters in normal physiology and liver disease
inferredcites →https://doi.org/10.1053/j.gastro.2005.08.052openalex-snapshot
Hepatocanalicular Transport Defects: Pathophysiologic Mechanisms of Rare Diseases
inferredcites →https://doi.org/10.1053/j.gastro.2010.07.001openalex-snapshot
Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2011.06.040openalex-snapshot
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1053/jhep.2001.25958openalex-snapshot
Suppression of Bile Acid Synthesis, But Not of Hepatic Cholesterol 7α–Hydroxylase Expression, by Obstructive Cholestasis in Humans
inferredcites →https://doi.org/10.1055/s-0030-1267539openalex-snapshot
Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1056/nejm200011163432007openalex-snapshot
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1074/jbc.m011610200openalex-snapshot
Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor
inferredcites →https://doi.org/10.1074/jbc.m111.305789openalex-snapshot
Glucose and Insulin Induction of Bile Acid Synthesis
inferredcites →https://doi.org/10.1074/jbc.m209387200openalex-snapshot
Bile Acids Stimulate cFLIP Phosphorylation Enhancing TRAIL-mediated Apoptosis
inferredcites →https://doi.org/10.1080/07853890410018790openalex-snapshot
The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts
inferredcites →https://doi.org/10.1097/meg.0b013e3282f4710aopenalex-snapshot
Bile acid levels are increased in the liver of patients with steatohepatitis
inferredcites →https://doi.org/10.1097/meg.0b013e328345c8c7openalex-snapshot
Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1111/j.1365-2036.2007.03522.xopenalex-snapshot
Review article: the function and regulation of proteins involved in bile salt biosynthesis and transport
inferredcites →https://doi.org/10.1136/gut.2003.037010openalex-snapshot
Adiponectin and its receptors in non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1152/ajpgi.00322.2009openalex-snapshot
The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
inferredcites →https://doi.org/10.1152/physrev.00027.2002openalex-snapshot
Bile Salt Transporters: Molecular Characterization, Function, and Regulation
inferredcites →https://doi.org/10.1155/2011/369168openalex-snapshot
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
inferredcites →https://doi.org/10.1172/jci4765openalex-snapshot
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
inferredcites →https://doi.org/10.1515/bc.2010.141openalex-snapshot
Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice
inferredcites →https://doi.org/10.2174/138161210791208929openalex-snapshot
Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4859731openalex-extracted
Daphnetin Alleviates Nash by Modulating Lipid Metabolism, Bile Acids and Gut Microbiota in Mcd Diet Mice
inferred← citeshttps://doi.org/10.1002/9781118663387.ch28openalex-snapshot
Bile acids and their receptors
inferred← citeshttps://doi.org/10.1002/bmc.5625openalex-snapshot
A simple and rapid liquid chromatography–tandem mass spectrometry method for the simultaneous determination of 15 bile acids in human serum and its application to patients with decompensated cirrhosis
inferred← citeshttps://doi.org/10.1002/hep.26896openalex-snapshot
The Hunt for Treatment Options of Fatty Liver Continues: Effects of Retinoic Acid on Hepatic Steatosis Reveal Novel Transcriptional Interactions of Nuclear Receptors
inferred← citeshttps://doi.org/10.1002/hep.27175openalex-snapshot
Saturated free fatty acids induce cholangiocyte lipoapoptosis
inferred← citeshttps://doi.org/10.1002/hep.29359openalex-snapshot
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
inferred← citeshttps://doi.org/10.1002/hep.29543openalex-snapshot
Bile acids in nonalcoholic steatohepatitis: Pathophysiological driving force or innocent bystanders?
inferred← citeshttps://doi.org/10.1002/hep.30612openalex-snapshot
Bile Acid Homeostasis in a Cholesterol 7α‐Hydroxylase and Sterol 27‐Hydroxylase Double Knockout Mouse Model
inferred← citeshttps://doi.org/10.1002/hep4.1490openalex-snapshot
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas
inferred← citeshttps://doi.org/10.1002/jbt.21831openalex-snapshot
Elevated cholesterol levels have a poor prognosis in a cholestasis scenario
inferred← citeshttps://doi.org/10.1002/jcla.21697openalex-snapshot
M30 Does Not Predict the Severity of Hepatosteatosis, Whereas Adiponectin Level Declined With Increase of ALT and the Severity of Hepatic Steatosis
inferred← citeshttps://doi.org/10.1002/jsfa.7764openalex-snapshot
Effect of prebiotics of Agave salmiana fed to healthy Wistar rats
inferred← citeshttps://doi.org/10.1002/mnfr.201400913openalex-snapshot
Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet‐induced mouse model of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/ntls.70069openalex-snapshot
Transcriptomics Analysis Reveals Dual Axes of Metabolic and Immune Dysregulation in the Progression of NAFLD to HCC
inferred← citeshttps://doi.org/10.1002/oby.20890openalex-snapshot
The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice
inferred← citeshttps://doi.org/10.1002/sscp.202300189openalex-snapshot
Comparison of metabolic differences between two geometrical isomers based on multi‐omics strategy
inferred← citeshttps://doi.org/10.1002/tkm2.1032openalex-snapshot
Changes in liver lipidomics associated with sodium cholate-induced liver injury and its prevention by boiogito, a Japanese herbal medicine, in mice
inferred← citeshttps://doi.org/10.1007/164_2019_229openalex-snapshot
Targeting Bile Acid-Activated Receptors in Bariatric Surgery
inferred← citeshttps://doi.org/10.1007/978-3-031-25828-2_7openalex-snapshot
Pathophysiology of Bile Acid Regulation
inferred← citeshttps://doi.org/10.1007/978-3-319-25065-6_5openalex-snapshot
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-662-62484-5_14openalex-snapshot
Diagnostik: Blutbasierte Marker
inferred← citeshttps://doi.org/10.1007/978-3-662-62484-5_5openalex-snapshot
Pathophysiologie: Lipidstoffwechsel
inferred← citeshttps://doi.org/10.1007/978-4-431-56062-3_10openalex-snapshot
Bile Acids and NAFLD/NASH
inferred← citeshttps://doi.org/10.1007/s00018-022-04658-8openalex-snapshot
Liver-derived metabolites as signaling molecules in fatty liver disease
inferred← citeshttps://doi.org/10.1007/s00210-015-1207-1openalex-snapshot
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis
inferred← citeshttps://doi.org/10.1007/s00281-021-00869-6openalex-snapshot
Role of bile acids in inflammatory liver diseases
inferred← citeshttps://doi.org/10.1007/s00424-013-1367-0openalex-snapshot
Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters
inferred← citeshttps://doi.org/10.1007/s00535-015-1148-yopenalex-snapshot
The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/s10620-015-3776-8openalex-snapshot
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1007/s11377-025-00878-zopenalex-snapshot
Metabolische Dysfunktion-assoziierte steatotische Lebererkrankung und hepatozelluläres Karzinom
inferred← citeshttps://doi.org/10.1007/s11695-015-1878-1openalex-snapshot
Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s12072-021-10134-5openalex-snapshot
Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/s12272-022-01419-wopenalex-snapshot
Non-alcoholic fatty liver disease and liver secretome
inferred← citeshttps://doi.org/10.1016/b978-1-63067-036-8.00028-7openalex-snapshot
Lipids, Low-Grade Chronic Inflammation and NAFLD
inferred← citeshttps://doi.org/10.1016/b978-3-437-06282-7.50008-5openalex-snapshot
ERKRANKUNGEN DER VERDAUUNGSORGANE
inferred← citeshttps://doi.org/10.1016/b978-3-437-21164-5.00027-1openalex-snapshot
Metabolisch assoziierte Fettlebererkrankung (MASLD)
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.12.011openalex-snapshot
Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.06.023openalex-snapshot
Animal models of NAFLD from a hepatologist's point of view
inferred← citeshttps://doi.org/10.1016/j.bbadis.2023.166639openalex-snapshot
Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.bcp.2013.08.015openalex-snapshot
Bile acid receptors in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.chmed.2024.11.002openalex-snapshot
Overexpression of SULT1E1 alleviates salt-processed Psoraleae Fructus-induced cholestatic liver damage
inferred← citeshttps://doi.org/10.1016/j.clnu.2021.04.008openalex-snapshot
Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults
inferred← citeshttps://doi.org/10.1016/j.diabet.2013.11.004openalex-snapshot
Adiponectin: A multitasking player in the field of liver diseases
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114903openalex-snapshot
Structural optimization and biological evaluation of 1-adamantylcarbonyl-4-phenylpiperazine derivatives as FXR agonists for NAFLD
inferred← citeshttps://doi.org/10.1016/j.ejphar.2018.02.002openalex-snapshot
Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity
inferred← citeshttps://doi.org/10.1016/j.etp.2014.04.004openalex-snapshot
Molecular mechanisms of liver injury: Apoptosis or necrosis
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2019.05.029openalex-snapshot
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.141151openalex-snapshot
Metabolic restoration: Rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2021.02.009openalex-snapshot
Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2025.101678openalex-snapshot
Intestinal Epithelial Cell-derived Osteopontin Protects Against Metabolic Dysfunction–associated Steatohepatitis by Modulating Bile Acid Composition and the Gut Microbiome
inferred← citeshttps://doi.org/10.1016/j.jep.2017.07.031openalex-snapshot
Analyzing the hepatoprotective effect of the Swertia cincta Burkill extract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes
inferred← citeshttps://doi.org/10.1016/j.jep.2020.113658openalex-snapshot
Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on α-naphthylisothiocyanate (ANIT) -induced cholestasis in rats
inferred← citeshttps://doi.org/10.1016/j.jep.2021.114955openalex-snapshot
Combination of molecular docking and liver transcription sequencing analysis for the evaluation of salt-processed psoraleae fructus-induced hepatotoxicity in ovariectomized mice
inferred← citeshttps://doi.org/10.1016/j.jep.2022.115164openalex-snapshot
Swertiamarin, an active iridoid glycoside from Swertia pseudochinensis H. Hara, protects against alpha-naphthylisothiocyanate-induced cholestasis by activating the farnesoid X receptor and bile acid excretion pathway
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.10.030openalex-snapshot
Hepatokines and adipokines in NASH-related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.01.020openalex-snapshot
Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.09.032openalex-snapshot
Bile acid metabolism and signalling in liver disease
inferred← citeshttps://doi.org/10.1016/j.joim.2026.03.003openalex-snapshot
Yinchenhao Decoction, a compound Chinese herbal medicine, for patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1016/j.jpha.2023.12.003openalex-snapshot
New advances of adiponectin in regulating obesity and related metabolic syndromes
inferred← citeshttps://doi.org/10.1016/j.jpha.2024.100979openalex-snapshot
Targeting NTCP for liver disease treatment: A promising strategy
inferred← citeshttps://doi.org/10.1016/j.livres.2023.09.002openalex-snapshot
Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.livres.2024.03.002openalex-snapshot
Targeting nuclear receptors for NASH/MASH: From bench to bedside
inferred← citeshttps://doi.org/10.1016/j.mam.2017.04.004openalex-snapshot
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.metabol.2016.02.014openalex-snapshot
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.metabol.2020.154457openalex-snapshot
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
inferred← citeshttps://doi.org/10.1016/j.molmet.2020.101119openalex-snapshot
Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.pharmr.2025.100073openalex-snapshot
Pathological and therapeutic roles of bile acid metabolism and signaling in hepatocellular carcinoma: Insights from human and mouse studies
inferred← citeshttps://doi.org/10.1016/j.phyplu.2021.100076openalex-snapshot
Protective effect of the ethyl acetate fraction of Qinghai-Tibet Plateau medicinal plant Chrysosplenium axillare Maxim. against ANIT-induced cholestatic liver injury in mice
inferred← citeshttps://doi.org/10.1016/j.semcancer.2022.02.004openalex-snapshot
The altered lipidome of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.taap.2015.01.020openalex-snapshot
Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis
inferred← citeshttps://doi.org/10.1016/j.tem.2017.11.002openalex-snapshot
Role of Bile Acids in Metabolic Control
inferred← citeshttps://doi.org/10.1016/j.yrtph.2024.105565openalex-snapshot
Biomonitoring and risk assessment of human exposure to triazole fungicides
inferred← citeshttps://doi.org/10.1016/s1665-2681(19)31170-6openalex-snapshot
The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/s1665-2681(19)31350-xopenalex-snapshot
The fate of fatty liver disease: of bile and fatty acids
inferred← citeshttps://doi.org/10.1021/acsami.6c04642openalex-snapshot
NaGdF 4 Nanoprobe-Enhanced Multiparametric MRI for Evaluating Diabetes Mellitus-Associated Hepatic Dysfunction and Precancerous Biliary Transformation
inferred← citeshttps://doi.org/10.1038/cddis.2013.499openalex-snapshot
Molecular mechanisms of hepatic apoptosis
inferred← citeshttps://doi.org/10.1038/cddis.2017.480openalex-snapshot
Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice
inferred← citeshttps://doi.org/10.1038/s41392-024-01811-6openalex-snapshot
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
inferred← citeshttps://doi.org/10.1038/s41522-023-00398-0openalex-snapshot
Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage
inferred← citeshttps://doi.org/10.1038/s41522-025-00706-wopenalex-snapshot
Targeted metabolomics reveals bioactive inflammatory mediators from gut into blood circulation in children with NAFLD
inferred← citeshttps://doi.org/10.1038/s41574-019-0266-7openalex-snapshot
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
inferred← citeshttps://doi.org/10.1038/s41575-018-0057-yopenalex-snapshot
Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer
inferred← citeshttps://doi.org/10.1038/s41575-021-00448-yopenalex-snapshot
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
inferred← citeshttps://doi.org/10.1038/s41575-021-00502-9openalex-snapshot
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
inferred← citeshttps://doi.org/10.1038/s41575-021-00566-7openalex-snapshot
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
inferred← citeshttps://doi.org/10.1038/s41598-018-33660-zopenalex-snapshot
Small heterodimer partner negatively regulates C-X-C motif chemokine ligand 2 in hepatocytes during liver inflammation
inferred← citeshttps://doi.org/10.1038/s41598-021-02144-yopenalex-snapshot
Circulating bile acids concentration is predictive of coronary artery disease in human
inferred← citeshttps://doi.org/10.1038/s41598-023-34137-4openalex-snapshot
Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury
inferred← citeshttps://doi.org/10.1038/s41598-023-42358-wopenalex-snapshot
Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice
inferred← citeshttps://doi.org/10.1038/s42255-021-00501-9openalex-snapshot
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
inferred← citeshttps://doi.org/10.1038/srep05832openalex-snapshot
Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
inferred← citeshttps://doi.org/10.1038/srep13058openalex-snapshot
Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
inferred← citeshttps://doi.org/10.1038/srep31829openalex-snapshot
Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport
inferred← citeshttps://doi.org/10.1038/srep34117openalex-snapshot
Myeloid Cell-Specific Lipin-1 Deficiency Stimulates Endocrine Adiponectin-FGF15 Axis and Ameliorates Ethanol-Induced Liver Injury in Mice
inferred← citeshttps://doi.org/10.1042/cs20120542openalex-snapshot
Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
inferred← citeshttps://doi.org/10.1053/j.gastro.2014.04.030openalex-snapshot
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
inferred← citeshttps://doi.org/10.1055/a-1880-2283openalex-snapshot
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
inferred← citeshttps://doi.org/10.1055/a-1880-2388openalex-snapshot
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025
inferred← citeshttps://doi.org/10.1055/s-0041-1731707openalex-snapshot
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
inferred← citeshttps://doi.org/10.1074/jbc.m116.737015openalex-snapshot
MitoNEET Deficiency Alleviates Experimental Alcoholic Steatohepatitis in Mice by Stimulating Endocrine Adiponectin-Fgf15 Axis
inferred← citeshttps://doi.org/10.1074/jbc.ra117.001653openalex-snapshot
Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1080/17425255.2017.1314461openalex-snapshot
Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1089/met.2013.0044openalex-snapshot
Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D 3 Levels
inferred← citeshttps://doi.org/10.1093/toxsci/kfu195openalex-snapshot
Glycodeoxycholic Acid Levels as Prognostic Biomarker in Acetaminophen-Induced Acute Liver Failure Patients
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000127openalex-snapshot
FXR and NASH: an avenue for tissue-specific regulation
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000234openalex-snapshot
Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000606openalex-snapshot
High-fat/high-sucrose diet results in a high rate of MASH with HCC in a mouse model of human-like bile acid composition
inferred← citeshttps://doi.org/10.1097/hep.0000000000001438openalex-snapshot
Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease
inferred← citeshttps://doi.org/10.1097/hep.0000000000001539openalex-snapshot
Bile acid signaling in MASLD: From pathogenesis to therapeutic applications
inferred← citeshttps://doi.org/10.1097/meg.0000000000002274openalex-snapshot
Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease
inferred← citeshttps://doi.org/10.1097/mol.0000000000000597openalex-snapshot
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
inferred← citeshttps://doi.org/10.1097/mpg.0000000000000809openalex-snapshot
Bile Acids as Biomarkers
inferred← citeshttps://doi.org/10.1097/mpg.0000000000002010openalex-snapshot
Bile Acids and the Gut Microbiome as Potential Targets for NAFLD Treatment
inferred← citeshttps://doi.org/10.1101/2025.11.18.25340381openalex-snapshot
Hepatic insulin resistance is the basis of bile acid dysmetabolism in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1111/acer.15081openalex-snapshot
Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages
inferred← citeshttps://doi.org/10.1111/apt.15035openalex-snapshot
Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose‐dependent changes with increase in fibrosis stage in patients with biopsy‐proven NAFLD
inferred← citeshttps://doi.org/10.1111/apt.16948openalex-snapshot
Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala
inferred← citeshttps://doi.org/10.1111/bcp.15990openalex-snapshot
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions
inferred← citeshttps://doi.org/10.1111/dom.14322openalex-snapshot
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
inferred← citeshttps://doi.org/10.1111/eci.12128openalex-snapshot
Intrahepatic cholestasis in common chronic liver diseases
inferred← citeshttps://doi.org/10.1111/hepr.12114openalex-snapshot
Serum adiponectin levels and hepatic diseases
inferred← citeshttps://doi.org/10.1111/jgh.13857openalex-snapshot
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
inferred← citeshttps://doi.org/10.1111/jgh.15709openalex-snapshot
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease
inferred← citeshttps://doi.org/10.1111/jgh.16544openalex-snapshot
The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury
inferred← citeshttps://doi.org/10.1111/liv.12456openalex-snapshot
Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
inferred← citeshttps://doi.org/10.1111/liv.12572openalex-snapshot
(Cleaved) CK 18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts
inferred← citeshttps://doi.org/10.1111/liv.12769openalex-snapshot
Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humans
inferred← citeshttps://doi.org/10.1124/dmd.118.082008openalex-snapshot
Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
inferred← citeshttps://doi.org/10.1136/gutjnl-2014-307024openalex-snapshot
Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently
inferred← citeshttps://doi.org/10.1136/gutjnl-2016-312975openalex-snapshot
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration
inferred← citeshttps://doi.org/10.1136/gutjnl-2017-314307openalex-snapshot
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
inferred← citeshttps://doi.org/10.1146/annurev-cellbio-100814-125241openalex-snapshot
The Hepatitis B Virus Receptor
inferred← citeshttps://doi.org/10.1152/ajpendo.00346.2024openalex-snapshot
Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis
inferred← citeshttps://doi.org/10.1152/ajpendo.00366.2014openalex-snapshot
CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice
inferred← citeshttps://doi.org/10.1152/ajpgi.00044.2018openalex-snapshot
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis
inferred← citeshttps://doi.org/10.1152/ajpgi.00165.2014openalex-snapshot
Protein kinase Cδ protects against bile acid apoptosis by suppressing proapoptotic JNK and BIM pathways in human and rat hepatocytes
inferred← citeshttps://doi.org/10.1152/ajpgi.00213.2016openalex-snapshot
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition
inferred← citeshttps://doi.org/10.1155/2014/757929openalex-snapshot
Biomarkers in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1155/2015/273595openalex-snapshot
Nonmedicinal Interventions in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1155/2018/2548154openalex-snapshot
Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression
inferred← citeshttps://doi.org/10.1159/000365886openalex-snapshot
Identifying Soluble Mediators of Nuclear Receptor and Insulin Signaling May Enhance Noninvasive Diagnosis of Fibrosis in Fatty Liver Disease
inferred← citeshttps://doi.org/10.1159/000371699openalex-snapshot
Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
inferred← citeshttps://doi.org/10.1159/000493259openalex-snapshot
Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research
inferred← citeshttps://doi.org/10.1172/jci.insight.137566openalex-snapshot
ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis
inferred← citeshttps://doi.org/10.1177/20420188221142452openalex-snapshot
Emerging pharmacological treatment options for MAFLD
inferred← citeshttps://doi.org/10.1186/1476-511x-13-69openalex-snapshot
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1186/s12864-015-2292-8openalex-snapshot
Liver transcriptomic networks reveal main biological processes associated with feed efficiency in beef cattle
inferred← citeshttps://doi.org/10.1186/s12876-019-1149-zopenalex-snapshot
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
inferred← citeshttps://doi.org/10.1186/s12906-015-0627-2openalex-snapshot
Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang
inferred← citeshttps://doi.org/10.1186/s12940-015-0066-zopenalex-snapshot
Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study
inferred← citeshttps://doi.org/10.1186/s12944-017-0551-1openalex-snapshot
Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study
inferred← citeshttps://doi.org/10.1186/s12944-023-01871-7openalex-snapshot
Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
inferred← citeshttps://doi.org/10.1186/s13020-021-00470-xopenalex-snapshot
Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
inferred← citeshttps://doi.org/10.1186/s40001-025-02837-4openalex-snapshot
Longitudinal serum total bile acid trajectories and risk of metabolic dysfunction-associated fatty liver disease: a retrospective cohort study
inferred← citeshttps://doi.org/10.1186/s43066-020-00043-xopenalex-snapshot
Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult
inferred← citeshttps://doi.org/10.1194/jlr.m078980openalex-snapshot
Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver
inferred← citeshttps://doi.org/10.1194/jlr.m093229openalex-snapshot
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1210/clinem/dgac659openalex-snapshot
Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention
inferred← citeshttps://doi.org/10.1210/er.2019-00034openalex-snapshot
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
inferred← citeshttps://doi.org/10.1210/jc.2017-01397openalex-snapshot
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
inferred← citeshttps://doi.org/10.12677/acm.2025.152338openalex-snapshot
The Correlation between NAFLD and T2DM
inferred← citeshttps://doi.org/10.12998/wjcc.v9.i23.6654openalex-snapshot
Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
inferred← citeshttps://doi.org/10.1371/journal.pone.0159217openalex-snapshot
Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0193824openalex-snapshot
Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
inferred← citeshttps://doi.org/10.14218/jcth.2021.00174openalex-snapshot
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
inferred← citeshttps://doi.org/10.14218/jcth.2022.00089openalex-snapshot
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.14309/ctg.0000000000000066openalex-snapshot
Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
inferred← citeshttps://doi.org/10.14309/ctg.0000000000000131openalex-snapshot
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
inferred← citeshttps://doi.org/10.1631/jzus.b1900158openalex-snapshot
Bile-ology: from bench to bedside
inferred← citeshttps://doi.org/10.1684/vir.2018.0716openalex-snapshot
Le transporteur d’acides biliaires NTCP, un acteur majeur dans l’infection par les virus humains des hépatites offrant de nouvelles perspectives thérapeutiques
inferred← citeshttps://doi.org/10.20463/pan.2024.0024openalex-snapshot
Effects of fermented oyster extract supplementation on free fatty acid and liver enzymes in older women with obesity
inferred← citeshttps://doi.org/10.20517/2394-5079.2020.56openalex-snapshot
Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.21037/hbsn-21-406openalex-snapshot
Controlling cholesterol entry into mitochondria, a key step for hepatocarcinogenesis in non-alcoholic steatohepatitis-related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-238299/v1openalex-snapshot
Hepatocyte Nuclear Factor 4 Alpha Attenuated Lipotoxicity, But Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease Model.
inferred← citeshttps://doi.org/10.2139/ssrn.6634819openalex-snapshot
Targeting Sodium Taurocholate Co-Transporting Polypeptide (NTCP) in Cholestatic Liver Disease: Therapeutic Potential and Clinical Implications
inferred← citeshttps://doi.org/10.22416/1382-4376-2023-33-2-79-86openalex-snapshot
Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
inferred← citeshttps://doi.org/10.22490/24629448.6882openalex-snapshot
Mecanismos fisiopatologicos de la dislipidemia
inferred← citeshttps://doi.org/10.33549/physiolres.933206openalex-snapshot
Boldine Attenuates Cholestasis Associated With Nonalcoholic Fatty Liver Disease in Hereditary Hypertriglyceridemic Rats Fed by High-Sucrose Diet
inferred← citeshttps://doi.org/10.3389/fendo.2020.572729openalex-snapshot
Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
inferred← citeshttps://doi.org/10.3389/fendo.2023.1156381openalex-snapshot
Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
inferred← citeshttps://doi.org/10.3389/fmicb.2020.555293openalex-snapshot
The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study
inferred← citeshttps://doi.org/10.3389/fmolb.2023.1164220openalex-snapshot
Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis
inferred← citeshttps://doi.org/10.3389/fphar.2015.00217openalex-snapshot
Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study
inferred← citeshttps://doi.org/10.3389/fphar.2022.1027731openalex-snapshot
Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress
inferred← citeshttps://doi.org/10.3389/fphar.2026.1917467openalex-snapshot
Gut microbiota and the gut–liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities
inferred← citeshttps://doi.org/10.3389/fphys.2026.1811118openalex-snapshot
The gut microbiota-bile acid-FXR axis in NAFLD: from progression to therapeutic applications
inferred← citeshttps://doi.org/10.3390/antiox9090808openalex-snapshot
Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation
inferred← citeshttps://doi.org/10.3390/biochem5030019openalex-snapshot
HCC in MASLD and ALD: Biochemical Pathways, Epidemiology, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.3390/biom13091356openalex-snapshot
Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/biom14070841openalex-snapshot
Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases
inferred← citeshttps://doi.org/10.3390/cells10020210openalex-snapshot
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
inferred← citeshttps://doi.org/10.3390/cells11243983openalex-snapshot
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
inferred← citeshttps://doi.org/10.3390/cells8111358openalex-snapshot
Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
inferred← citeshttps://doi.org/10.3390/cells9112458openalex-snapshot
Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
inferred← citeshttps://doi.org/10.3390/cimb45010031openalex-snapshot
Protective Effect of Vitamin D against Hepatic Molecular Apoptosis Caused by a High-Fat Diet in Rats
inferred← citeshttps://doi.org/10.3390/ijms19072069openalex-snapshot
Update on FXR Biology: Promising Therapeutic Target?
inferred← citeshttps://doi.org/10.3390/ijms19103188openalex-snapshot
Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
inferred← citeshttps://doi.org/10.3390/ijms21155242openalex-snapshot
Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?
inferred← citeshttps://doi.org/10.3390/ijms21218308openalex-snapshot
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
inferred← citeshttps://doi.org/10.3390/ijms22010051openalex-snapshot
Deficiency in Tissue Non-Specific Alkaline Phosphatase Leads to Steatohepatitis in Mice Fed a High Fat Diet Similar to That Produced by a Methionine and Choline Deficient Diet
showing the first 200 of 231 · page through all 231
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.